On Tuesday, Passage Bio Inc (NASDAQ: PASG) opened higher 5.02% from the last session, before settling in for the closing price of $0.33. Price fluctuations for PASG have ranged from $0.26 to $1.33 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -1.48%. Company’s average yearly earnings per share was noted 31.21% at the time writing. With a float of $52.62 million, this company’s outstanding shares have now reached $62.15 million.
The extent of productivity of a business whose workforce counts for 60 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Passage Bio Inc (PASG) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Passage Bio Inc is 15.33%, while institutional ownership is 43.10%. The most recent insider transaction that took place on Jun 24 ’25, was worth 378,364. Before that another transaction happened on Apr 23 ’25, when Company’s 10% Owner sold 89,328 for $0.34, making the entire transaction worth $30,372. This insider now owns 6,718,195 shares in total.
Passage Bio Inc (PASG) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 31.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.74% during the next five years compared to -1.48% drop over the previous five years of trading.
Passage Bio Inc (NASDAQ: PASG) Trading Performance Indicators
Check out the current performance indicators for Passage Bio Inc (PASG). In the past quarter, the stock posted a quick ratio of 3.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Passage Bio Inc (PASG)
The latest stats from [Passage Bio Inc, PASG] show that its last 5-days average volume of 0.33 million was superior to 0.29 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 10.70%.
During the past 100 days, Passage Bio Inc’s (PASG) raw stochastic average was set at 25.66%, which indicates a significant increase from 11.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 99.80% in the past 14 days, which was lower than the 110.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3669, while its 200-day Moving Average is $0.5401. Now, the first resistance to watch is $0.3661. This is followed by the second major resistance level at $0.3807. The third major resistance level sits at $0.3962. If the price goes on to break the first support level at $0.3360, it is likely to go to the next support level at $0.3205. Assuming the price breaks the second support level, the third support level stands at $0.3059.
Passage Bio Inc (NASDAQ: PASG) Key Stats
There are currently 62,148K shares outstanding in the company with a market cap of 21.85 million. Presently, the company’s annual sales total 0 K according to its annual income of -64,770 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -15,410 K.
